China
· Delayed Price · Currency is CNY Acrobiosystems Statistics
Total Valuation
Acrobiosystems has a market cap or net worth of CNY 6.33 billion. The enterprise value is 4.61 billion.
| Market Cap | 6.33B |
| Enterprise Value | 4.61B |
Important Dates
The next estimated earnings date is Friday, August 29, 2025.
| Earnings Date | Aug 29, 2025 |
| Ex-Dividend Date | Jan 24, 2025 |
Share Statistics
Acrobiosystems has 119.77 million shares outstanding. The number of shares has increased by 0.11% in one year.
| Current Share Class | 119.77M |
| Shares Outstanding | 119.77M |
| Shares Change (YoY) | +0.11% |
| Shares Change (QoQ) | -0.69% |
| Owned by Insiders (%) | 37.25% |
| Owned by Institutions (%) | 15.23% |
| Float | 61.33M |
Valuation Ratios
The trailing PE ratio is 47.48 and the forward PE ratio is 39.71.
| PE Ratio | 47.48 |
| Forward PE | 39.71 |
| PS Ratio | 9.24 |
| PB Ratio | 2.42 |
| P/TBV Ratio | 2.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 73.58 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 36.36, with an EV/FCF ratio of -50.24.
| EV / Earnings | 34.50 |
| EV / Sales | 6.73 |
| EV / EBITDA | 36.36 |
| EV / EBIT | 62.23 |
| EV / FCF | -50.24 |
Financial Position
The company has a current ratio of 11.04, with a Debt / Equity ratio of 0.04.
| Current Ratio | 11.04 |
| Quick Ratio | 9.80 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.78 |
| Debt / FCF | -1.07 |
| Interest Coverage | 14.85 |
Financial Efficiency
Return on equity (ROE) is 5.01% and return on invested capital (ROIC) is 1.71%.
| Return on Equity (ROE) | 5.01% |
| Return on Assets (ROA) | 1.64% |
| Return on Invested Capital (ROIC) | 1.71% |
| Return on Capital Employed (ROCE) | 2.81% |
| Revenue Per Employee | 788,853 |
| Profits Per Employee | 153,900 |
| Employee Count | 869 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 0.58 |
Taxes
In the past 12 months, Acrobiosystems has paid 5.68 million in taxes.
| Income Tax | 5.68M |
| Effective Tax Rate | 4.15% |
Stock Price Statistics
The stock price has increased by +42.99% in the last 52 weeks. The beta is 0.81, so Acrobiosystems's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | +42.99% |
| 50-Day Moving Average | 49.55 |
| 200-Day Moving Average | 46.27 |
| Relative Strength Index (RSI) | 48.16 |
| Average Volume (20 Days) | 2,359,316 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Acrobiosystems had revenue of CNY 685.51 million and earned 133.74 million in profits. Earnings per share was 1.11.
| Revenue | 685.51M |
| Gross Profit | 580.11M |
| Operating Income | 74.13M |
| Pretax Income | 136.81M |
| Net Income | 133.74M |
| EBITDA | 104.74M |
| EBIT | 74.13M |
| Earnings Per Share (EPS) | 1.11 |
Balance Sheet
The company has 1.81 billion in cash and 98.44 million in debt, giving a net cash position of 1.72 billion or 14.33 per share.
| Cash & Cash Equivalents | 1.81B |
| Total Debt | 98.44M |
| Net Cash | 1.72B |
| Net Cash Per Share | 14.33 |
| Equity (Book Value) | 2.62B |
| Book Value Per Share | 21.89 |
| Working Capital | 1.97B |
Cash Flow
In the last 12 months, operating cash flow was 86.09 million and capital expenditures -177.91 million, giving a free cash flow of -91.83 million.
| Operating Cash Flow | 86.09M |
| Capital Expenditures | -177.91M |
| Free Cash Flow | -91.83M |
| FCF Per Share | -0.77 |
Margins
Gross margin is 84.62%, with operating and profit margins of 10.81% and 19.51%.
| Gross Margin | 84.62% |
| Operating Margin | 10.81% |
| Pretax Margin | 19.96% |
| Profit Margin | 19.51% |
| EBITDA Margin | 15.28% |
| EBIT Margin | 10.81% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.80, which amounts to a dividend yield of 1.47%.
| Dividend Per Share | 0.80 |
| Dividend Yield | 1.47% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 108.96% |
| Buyback Yield | -0.11% |
| Shareholder Yield | 1.36% |
| Earnings Yield | 2.11% |
| FCF Yield | -1.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 7, 2023. It was a forward split with a ratio of 1.5.
| Last Split Date | Jun 7, 2023 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
Acrobiosystems has an Altman Z-Score of 15.37 and a Piotroski F-Score of 4.
| Altman Z-Score | 15.37 |
| Piotroski F-Score | 4 |